{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:51:45Z","timestamp":1793170305279,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370988"],"award-info":[{"award-number":["32370988"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-51414-6","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:02:45Z","timestamp":1723561365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration"],"prefix":"10.1038","volume":"15","author":[{"given":"Linjing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengfeng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4831-7532","authenticated-orcid":false,"given":"Mingjun","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9113-2433","authenticated-orcid":false,"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5772-9482","authenticated-orcid":false,"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengya","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengshi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doudou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuncheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinxue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9300-6257","authenticated-orcid":false,"given":"Sheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4792-6364","authenticated-orcid":false,"given":"Peng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-9950","authenticated-orcid":false,"given":"Hongxia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0672-948X","authenticated-orcid":false,"given":"Zhiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-509X","authenticated-orcid":false,"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3507-3969","authenticated-orcid":false,"given":"Yaxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0464-0964","authenticated-orcid":false,"given":"Yalan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2829-6654","authenticated-orcid":false,"given":"Xilin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"51414_CR1","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/S0140-6736(21)00570-5","volume":"397","author":"P Van de Perre","year":"2021","unstructured":"Van de Perre, P. et al. Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions. Lancet 397, 1316\u20131324 (2021).","journal-title":"Lancet"},{"key":"51414_CR2","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1016\/S2352-3018(20)30172-7","volume":"7","author":"A Gupta-Wright","year":"2020","unstructured":"Gupta-Wright, A. et al. Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study. Lancet HIV 7, e620\u2013e628 (2020).","journal-title":"Lancet HIV"},{"key":"51414_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","volume":"18","author":"RK Gupta","year":"2018","unstructured":"Gupta, R. K. et al. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis. Lancet Infect. Dis. 18, 346\u2013355 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"51414_CR4","doi-asserted-by":"publisher","first-page":"eaaz2686","DOI":"10.1126\/scitranslmed.aaz2686","volume":"11","author":"BF Haynes","year":"2019","unstructured":"Haynes, B. F., Burton, D. R. & Mascola, J. R. Multiple roles for HIV broadly neutralizing antibodies. Sci. Transl. Med. 11, eaaz2686 (2019).","journal-title":"Sci. Transl. Med."},{"key":"51414_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41591-019-0412-8","volume":"25","author":"M Caskey","year":"2019","unstructured":"Caskey, M., Klein, F. & Nussenzweig, M. C. Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic. Nat. Med. 25, 547\u2013553 (2019).","journal-title":"Nat. Med."},{"key":"51414_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJMoa1711460","volume":"379","author":"B Emu","year":"2018","unstructured":"Emu, B. et al. Phase 3 study of ibalizumab for multidrug-resistant HIV-1. N. Engl. J. Med. 379, 645\u2013654 (2018).","journal-title":"N. Engl. J. Med."},{"key":"51414_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40265-020-01258-3","volume":"80","author":"HA Blair","year":"2020","unstructured":"Blair, H. A. Ibalizumab: a review in multidrug-resistant HIV-1 infection. Drugs 80, 189\u2013196 (2020).","journal-title":"Drugs"},{"key":"51414_CR8","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1172\/JCI96764","volume":"128","author":"X Wu","year":"2018","unstructured":"Wu, X. et al. Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice. J. Clin. Invest. 128, 2239\u20132251 (2018).","journal-title":"J. Clin. Invest."},{"key":"51414_CR9","doi-asserted-by":"publisher","first-page":"109611","DOI":"10.1016\/j.celrep.2021.109611","volume":"36","author":"M Niu","year":"2021","unstructured":"Niu, M. et al. Tandem bispecific antibody prevents pathogenic SHIVSF162P3CN infection and disease progression. Cell Rep. 36, 109611 (2021).","journal-title":"Cell Rep."},{"key":"51414_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00253-007-1142-2","volume":"77","author":"MM Harmsen","year":"2007","unstructured":"Harmsen, M. M. & De Haard, H. J. Properties, production, and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 77, 13\u201322 (2007).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"51414_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/363446a0","volume":"363","author":"C Hamerscasterman","year":"1993","unstructured":"Hamerscasterman, C. et al. Naturally-occurring antibodies devoid of light-chains. Nature 363, 446\u2013448 (1993).","journal-title":"Nature"},{"key":"51414_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","volume":"34","author":"I Jovcevska","year":"2020","unstructured":"Jovcevska, I. & Muyldermans, S. The therapeutic potential of nanobodies. Biodrugs 34, 11\u201326 (2020).","journal-title":"Biodrugs"},{"key":"51414_CR13","doi-asserted-by":"crossref","unstructured":"Muyldermans, S. Applications of Nanobodies. Annu Rev Anim Biosci. 9, 401\u2013421 (2021).","DOI":"10.1146\/annurev-animal-021419-083831"},{"key":"51414_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s44321-024-00026-0","volume":"16","author":"M Ji","year":"2024","unstructured":"Ji, M. et al. Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody. EMBO Mol. Med. 16, 575\u2013595 (2024).","journal-title":"EMBO Mol. Med."},{"key":"51414_CR15","doi-asserted-by":"crossref","unstructured":"Wu, X. et al. A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration. Cell Rep. 37, 109869 (2021).","DOI":"10.1016\/j.celrep.2021.109869"},{"key":"51414_CR16","doi-asserted-by":"publisher","first-page":"865401","DOI":"10.3389\/fimmu.2022.865401","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. Short-term instantaneous prophylaxis and efficient treatment against SARS-CoV-2 in hACE2 mice conferred by an intranasal nanobody (Nb22). Front. Immunol. 13, 865401 (2022).","journal-title":"Front. Immunol."},{"key":"51414_CR17","doi-asserted-by":"publisher","first-page":"eabe6230","DOI":"10.1126\/science.abe6230","volume":"371","author":"PA Koenig","year":"2021","unstructured":"Koenig, P. A. et al. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science 371, eabe6230 (2021).","journal-title":"Science"},{"key":"51414_CR18","doi-asserted-by":"publisher","first-page":"690742","DOI":"10.3389\/fimmu.2021.690742","volume":"12","author":"F Chen","year":"2021","unstructured":"Chen, F., Liu, Z. & Jiang, F. Prospects of neutralizing nanobodies against SARS-CoV-2. Front. Immunol. 12, 690742 (2021).","journal-title":"Front. Immunol."},{"key":"51414_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa1806311","volume":"380","author":"M Scully","year":"2019","unstructured":"Scully, M. et al. Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N. Engl. J. Med. 380, 335\u2013346 (2019).","journal-title":"N. Engl. J. Med."},{"key":"51414_CR20","doi-asserted-by":"publisher","first-page":"978513","DOI":"10.3389\/fimmu.2022.978513","volume":"13","author":"F Zheng","year":"2022","unstructured":"Zheng, F. et al. Applications of nanobodies in brain diseases. Front. Immunol. 13, 978513 (2022).","journal-title":"Front. Immunol."},{"key":"51414_CR21","doi-asserted-by":"publisher","first-page":"799910","DOI":"10.3389\/fimmu.2021.799910","volume":"12","author":"B Traenkle","year":"2021","unstructured":"Traenkle, B. et al. Single-domain antibodies for targeting, detection, and in vivo imaging of human CD4(+) cells. Front. Immunol. 12, 799910 (2021).","journal-title":"Front. Immunol."},{"key":"51414_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep46733","volume":"7","author":"LW Duan","year":"2017","unstructured":"Duan, L. W. et al. A non-canonical binding interface in the crystal structure of HIV-1 gp120 core in complex with CD4. Sci. Rep. 7, 46733 (2017).","journal-title":"Sci. Rep."},{"key":"51414_CR23","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/31405","volume":"393","author":"PD Kwong","year":"1998","unstructured":"Kwong, P. D. et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648\u2013659 (1998).","journal-title":"Nature"},{"key":"51414_CR24","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.str.2010.09.017","volume":"18","author":"MM Freeman","year":"2010","unstructured":"Freeman, M. M. et al. Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody. Structure 18, 1632\u20131641 (2010).","journal-title":"Structure"},{"key":"51414_CR25","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1073\/pnas.1118801109","volume":"109","author":"Y Yin","year":"2012","unstructured":"Yin, Y., Wang, X. X. & Mariuzza, R. A. Crystal structure of a complete ternary complex of T-cell receptor, peptide-MHC, and CD4. Proc. Natl Acad. Sci. USA 109, 5405\u20135410 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"51414_CR26","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1128\/JVI.02853-13","volume":"88","author":"A deCamp","year":"2014","unstructured":"deCamp, A. et al. Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 88, 2489\u20132507 (2014).","journal-title":"J. Virol."},{"key":"51414_CR27","doi-asserted-by":"publisher","first-page":"e1007819","DOI":"10.1371\/journal.ppat.1007819","volume":"15","author":"P Zhou","year":"2019","unstructured":"Zhou, P. et al. Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies. Plos Pathog. 15, e1007819 (2019).","journal-title":"Plos Pathog."},{"key":"51414_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/QAD.0000000000003371","volume":"37","author":"J Lucas","year":"2023","unstructured":"Lucas, J. et al. Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains. Aids 37, 43\u201349 (2023).","journal-title":"Aids"},{"key":"51414_CR29","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.cell.2016.05.024","volume":"165","author":"YX Huang","year":"2016","unstructured":"Huang, Y. X. et al. Engineered bispecific antibodies with exquisite HIV-1-neutralizing activity. Cell 165, 1621\u20131631 (2016).","journal-title":"Cell"},{"key":"51414_CR30","doi-asserted-by":"publisher","first-page":"13540","DOI":"10.1073\/pnas.1304985110","volume":"110","author":"CS Pace","year":"2013","unstructured":"Pace, C. S. et al. Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1. Proc. Natl Acad. Sci. USA 110, 13540\u201313545 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"51414_CR31","doi-asserted-by":"publisher","first-page":"712122","DOI":"10.3389\/fimmu.2021.712122","volume":"12","author":"SR Walsh","year":"2021","unstructured":"Walsh, S. R. & Seaman, M. S. Broadly neutralizing antibodies for HIV-1 prevention. Front. Immunol. 12, 712122 (2021).","journal-title":"Front. Immunol."},{"key":"51414_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nri3516","volume":"13","author":"PD Kwong","year":"2013","unstructured":"Kwong, P. D., Mascola, J. R. & Nabel, G. J. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning. Nat. Rev. Immunol. 13, 693\u2013701 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"51414_CR33","doi-asserted-by":"publisher","first-page":"e136855","DOI":"10.1172\/jci.insight.136855","volume":"5","author":"X Wu","year":"2020","unstructured":"Wu, X. et al. A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo. JCI insight 5, e136855 (2020).","journal-title":"JCI insight"},{"key":"51414_CR34","first-page":"45","volume":"2","author":"X Wu","year":"2019","unstructured":"Wu, X. et al. Induction of neutralizing antibodies by human papillomavirus vaccine generated in mammalian cells. Antib. Ther. 2, 45\u201353 (2019).","journal-title":"Antib. Ther."},{"key":"51414_CR35","doi-asserted-by":"publisher","unstructured":"Baral, T. N., MacKenzie, R. & Arbabi Ghahroudi, M. Single-domain antibodies and their utility. Current protocols in immunology\/edited by John E. Coligan\u2026 [et al.] 103, Unit 2 17, https:\/\/doi.org\/10.1002\/0471142735.im0217s103 (2013).","DOI":"10.1002\/0471142735.im0217s103"},{"key":"51414_CR36","doi-asserted-by":"publisher","first-page":"20565","DOI":"10.1073\/pnas.1012865107","volume":"107","author":"S Jahnichen","year":"2010","unstructured":"Jahnichen, S. et al. CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells. Proc. Natl Acad. Sci. USA 107, 20565\u201320570 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"51414_CR37","doi-asserted-by":"publisher","first-page":"14531","DOI":"10.1074\/jbc.M111.224527","volume":"286","author":"H Shang","year":"2011","unstructured":"Shang, H. et al. Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China. J. Biol. Chem. 286, 14531\u201314541 (2011).","journal-title":"J. Biol. Chem."},{"key":"51414_CR38","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s11481-016-9654-0","volume":"11","author":"X Wu","year":"2016","unstructured":"Wu, X. et al. Brain invasion by CD4(+) T cells infected with a transmitted\/founder HIV-1BJZS7 during acute stage in humanized mice. J. NeuroImmune Pharmacol. J. Soc. NeuroImmune Pharmacol. 11, 572\u2013583 (2016).","journal-title":"J. NeuroImmune Pharmacol. J. Soc. NeuroImmune Pharmacol."},{"key":"51414_CR39","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1107\/S0907444906019949","volume":"62","author":"W Minor","year":"2006","unstructured":"Minor, W., Cymborowski, M., Otwinowski, Z. & Chruszcz, M. HKL-3000: the integration of data reduction and structure solution - from diffraction images to an initial model in minutes. Acta Crystallogr. Sect. D. -Struct. Biol. 62, 859\u2013866 (2006).","journal-title":"Acta Crystallogr. Sect. D. -Struct. Biol."},{"key":"51414_CR40","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ Mccoy","year":"2007","unstructured":"Mccoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"51414_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D. -Struct. Biol. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. Sect. D. -Struct. Biol."},{"key":"51414_CR42","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D. -Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. Sect. D. -Biol. Crystallogr."},{"key":"51414_CR43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"51414_CR44","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Modeling 51, 2778\u20132786 (2011).","journal-title":"J. Chem. Inf. Modeling"},{"key":"51414_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/330256a0","volume":"330","author":"C Doyle","year":"1987","unstructured":"Doyle, C. & Strominger, J. L. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330, 256\u2013259 (1987).","journal-title":"Nature"},{"key":"51414_CR46","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"key":"51414_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"51414_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"51414_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y","volume":"38","author":"MF Sanner","year":"1996","unstructured":"Sanner, M. F., Olson, A. J. & Spehner, J. C. Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 38, 305\u2013320 (1996).","journal-title":"Biopolymers"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51414-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T16:18:49Z","timestamp":1723565929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51414-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51414"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-51414-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3443144\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"30 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6961"}}